Back
OceanFirst Financial Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
39
OCFC
OceanFirst Financial
Last Price:
$18.03
Seasonality Move:
1.58%
Buy
57
SRPT
Sarepta Therapeutics
Last Price:
$106.83
Seasonality Move:
8.04%
Sell
39
OceanFirst Financial (OCFC)
is a Sell
Is OceanFirst Financial a Buy, Sell or Hold?
-
The current OceanFirst Financial [OCFC] share price is $18.03. The Score for OCFC is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
OCFC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $106.89. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
OCFC Stock Price Chart
What is OceanFirst Financial's stock price today?
-
The OceanFirst Financial share price today is $18.03Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCFC is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $106.89Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.
OCFC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 42.19 | Sell |
Chaikin Money Flow: | 161334 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.7 - 18.54) | Sell |
Bollinger Bands (100): | (17.65 - 19.87) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.25 | Sell |
Relative Strength Index (14 RSI): | 41.97 | Sell |
Chaikin Money Flow: | 469170 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (106.93 - 115.87) | Sell |
Bollinger Bands (100): | (111.92 - 127.28) | Sell |
OCFC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.89 | Buy |
20-day SMA: | 17.98 | Buy |
50-day SMA: | 18.2 | Sell |
200-day SMA: | 17.59 | Buy |
8-day EMA: | 17.89 | Buy |
20-day EMA: | 18.04 | Sell |
50-day EMA: | 18.31 | Sell |
200-day EMA: | 17.85 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 106.35 | Buy |
20-day SMA: | 109.97 | Sell |
50-day SMA: | 116.57 | Sell |
200-day SMA: | 127.54 | Sell |
8-day EMA: | 106.76 | Buy |
20-day EMA: | 109.7 | Sell |
50-day EMA: | 114.67 | Sell |
200-day EMA: | 122.08 | Sell |
OceanFirst Financial Earnings Growth & OCFC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.03 per share, and an increase next year of $0.46 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.86 per share, a decrease next quarter of $0.29 per share, an increase this year of $7.95 per share, and an increase next year of $4.16 per share.
OceanFirst Financial Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |